Image Analysis Group, Imaging Experts to Support Clinical Trials

NEWS

IAG and Picture Health Announce Strategic Partnership

to Advance AI-Driven Imaging Endpoints in Oncology Clinical Trials.

Meet Image Analysis Group at Key Industry Events this June!

Schedule DYNAMIKA demo at ASCO or EULAR. Meet IAG’s CEO at Jefferies!

Image Analysis Group and Alimentiev Announce Partnership

Partners will Offer Best-in-Class Solutions in GI, Obesity, NASH / MASH Trials.

IAG is Attending the WCO-IOF-ESCEO Congress in Rome

Meet our team at the Osteo Congress of the year!

IAG will Attend IO360 in Boston, Massachusetts, 24 – 26 Mar

IAG is sponsoring and speaking at IO360. Schedule a meeting to connect.

Dr. Olga Kubassova to Deliver Keynote Lecture at the IBD Summitt

The President of IAG is invited to the 1st International Summit of Inflammatory Bowel Disease Monitoring.

Image Analysis Group Announces Release of DYNAMIKA V7

Image Analysis Group has released DYNAMIKA V.7, the award-winning cloud platform for clinical trial imaging. DYNAMIKA V.7 has achieved the British Standards Institute (BSI) surveillance audit certification following a recent SOC II Type I compliance certification.

IAG Wins in the 2024 Pharmaceutical Technology Excellence Awards

DYNAMIKA wins in the Innovation Category, supported by GlobalData.

VIEWS

FDA Guidance for Industry: Obesity and Overweight

Developing Drugs and Biological Products for Weight Reduction, with added imaging expertise

Embracing Digital Innovation in Digestive Disease Drug Development

Share IAG’s experience in using Medical Imaging and A.I. in early and late phase clinical trials.

The Transformative Power of AI in Oncology Drug Development

Share IAG’s experience in using Medical Imaging and A.I. in early and late phase clinical trials.

Bone Health: New Drugs vs New Tools

The field of bone health is undergoing unprecedented advancements, with novel imaging techniques deployed to take novel platforms through approvals.

Cartilage Repair: Imaging in Treatment Advancements

Critical Role of Imaging is Crucial in Drug Development

Getting approval: the EMA and the FDA

Thinking through drug approval: the FDA and EMA and their requirements.

Imaging Power in Alzheimer’s Disease (AD) Studies

Breakthroughs in AD research and trials rely on accurate imaging and its interpretation.

A Story started by our President, Dr Olga Kubassova

While studying for her PhD at Leeds, UK Olga Kubassova began work on commercialising her research.

Image Analysis Group (IAG)
IAG, a pioneering imaging Clinical Research Organization (iCRO), seamlessly blends medical acumen, operational excellence, and cutting-edge AI to accelerate drug development. Since 2007, we’ve been the trusted partner for global biotech and pharma, expertly managing imaging across Phase I-III trials and real-world evidence studies in diverse therapeutic areas.
Our award-winning DYNAMIKA platform ensures unparalleled data integrity, while our innovative approach consistently unlocks and amplifies the value of novel therapies.
Partner with IAG to transform your clinical trials and maximize your therapeutic asset’s market potential.

Email: imaging.experts@ia-grp.com

Will you use imaging to assess safety or efficacy of a new drug candidate?

* imaging strategy and endpoints
* site feasibility
* execution and data management
* working with your CRO
* use of AI and patient consent